Therefore, these findings indicate that SP cells are likely to be a major driving force of CRC resistance to FOLFOX, indicating that the CD44v6-YB-1 signaling pathway may be an important target for eliminating CICs in CRC. Here, YBX1 is linked to colorectal carcinoma.